Crestline Management’s Clorox CLX Stock Holding History

Crestline Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-36,000	Closed	-$5.85M	–	121
2024 Q4	$5.85M	Buy	+36,000	New	+$5.89M	0.19%	119
2022 Q3	–	Sell	-4,000	Closed	-$564K	–	222
2022 Q2	$564K	Buy	+4,000	New	+$571K	0.07%	155

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Crestline Management's CLX Position: Q1 2025 in Review

Crestline Management sold out of Clorox (CLX) in Q1 2025, closing a stake of 36,000 shares — an estimated $5.85M sold.

Crestline Management first reported a position in CLX in Q2 2022 and held it in 2 quarters. The position peaked at $5.85M in Q4 2024. 1,188 funds tracked by Wall St. Rank hold CLX as of Q1 2025.

Crestline Management reported no remaining Clorox position as of Q1 2025 after selling out during the quarter.
Crestline Management sold 36,000 Clorox shares in Q1 2025, an estimated $5.85M.
Crestline Management first reported a position in Clorox in Q2 2022 and held it in 2 quarters.
Crestline Management's Clorox position peaked at $5.85M in Q4 2024.
1,188 funds tracked by Wall St. Rank held Clorox as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.